Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Sept 2013 for Tempest Therapeutics, Inc., €17k.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +52.7%Entry US$28,752.75 · Close at T+365 US$43,904.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Christopher A. Bleck: trading record in brief
Our data holds just one disclosure by Christopher A. Bleck, dated 12 September 2013, reporting an open-market purchase worth €17k in Tempest Therapeutics, Inc. Further filings will be added here. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christopher A. Bleck
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 2,000 shares@ US$11.15Common StockSEC:0001104659-13-069573:0Canonical exit: 10 Dec 2013 (T+90)
1 of 1 declaration
